INKT

MiNK Therapeutics (INKT)

About MiNK Therapeutics (INKT)

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded by Garo H. Armen in 2017 and is headquartered in New York, NY.

Details

Daily high

$12.51

Daily low

$12.01

Price at open

$12.33

52 Week High

$76.00

52 Week Low

$6.80

Market cap

60.5M

Dividend yield

0.00%

Volume

19,826

Avg. volume

46,746

P/E ratio

-4.28

MiNK Therapeutics News